Delivery Order SPE2DB20D7059-SPE2DB25FQET3
Award Date 4/24/25
Potential Completion Date 5/15/25
Potential Value $2.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $72,034 firm fixed-price delivery order from the Defense Logistics Agency (DLA) for XOLAIR 150 mg/ml syringes. This competitively awarded contract, with no set-aside designation, is scheduled for completion by May 15, 2025. The delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of Xolair 150 mg/ml syringes, with a firm fixed price ceiling value of $6,483.06 and an ultimate completion date of June 24, 2025. This non-set-aside, competitively awarded contract represents a single delivery order under the company's larger pharmaceutical supply framework with the federal government. The place of performance is listed as AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain for XOLAIR 150 mg/ml syrup on August 14, 2025. The contract is a firm fixed price delivery order with a ceiling value of $4,322.10 and an ultimate completion date of September 5, 2025. This award represents a competitive procurement with no set-aside designation and is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,881.36 to AmerisourceBergen Drug Corp for the supply of XOLAIR 150 mg/mL syringes. This firm fixed price, competitively awarded delivery order was issued on April 24, 2025, with an ultimate completion date of May 15, 2025. The product will be delivered to Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $72,034 delivery order to AmerisourceBergen Drug Corp on July 3, 2025, for the supply of Xolair 150 mg/mL syringes, with completion scheduled for July 25, 2025. This firm fixed-price, non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $16,685 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XOLAIR 150 mg/1.2 ml powder vials. The contract was competitively awarded with no set-aside designation and is scheduled for completion by July 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $8,644.08 by the Defense Department's Medical Supply Chain to deliver XOLAIR 150 mg/mL syringes. The contract, awarded on July 15, 2025, is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and carries no set-aside designation. The pharmaceutical product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $8,644.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for XOLAIR 150 mg/ml syringes on June 16, 2025, with completion targeted for July 9, 2025. This non-set-aside award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order valued at $3,601.70 to AmerisourceBergen Drug Corp for XOLAIR 150 mg/mL syringes. This competitively awarded, firm fixed-price contract was issued on July 23, 2025, with an ultimate completion date of August 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. XOLAIR (omalizumab) is a monoclonal antibody...
- The Defense Logistics Agency awarded a delivery order valued at $10,805.10 to AmerisourceBergen Drug Corp for Xolair 150 mg/ml syringes, with an ultimate completion date of September 2, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and...